Cargando…
Signal transducer and activator of transcription 3‐mediated CD133 up‐regulation contributes to promotion of hepatocellular carcinoma
Enhanced expression of the cancer stem cell (CSC) marker, CD133, is closely associated with a higher rate of tumor formation and poor prognosis in hepatocellular carcinoma (HCC) patients. Despite its clinical significance, the molecular mechanism underlying the deregulation of CD133 during tumor pro...
Autores principales: | Won, Cheolhee, Kim, Byung‐Hak, Yi, Eun Hee, Choi, Kyung‐Ju, Kim, Eun‐Kyung, Jeong, Jong‐Min, Lee, Jae‐Ho, Jang, Ja‐June, Yoon, Jung‐Hwan, Jeong, Won‐Il, Park, In‐Chul, Kim, Tae Woo, Bae, Sun Sik, Factor, Valentina M., Ma, Stephanie, Thorgeirsson, Snorri S., Lee, Yun‐Han, Ye, Sang‐Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049669/ https://www.ncbi.nlm.nih.gov/pubmed/26154152 http://dx.doi.org/10.1002/hep.27968 |
Ejemplares similares
-
A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma
por: Banerjee, Sudeep, et al.
Publicado: (2015) -
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
por: Andresen, Kim, et al.
Publicado: (2015) -
Down‐regulation of TIMP2 by HIF‐1α/miR‐210/HIF‐3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma
por: Kai, Alan Ka‐Lun, et al.
Publicado: (2016) -
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer
por: Aleksandrova, Krasimira, et al.
Publicado: (2014) -
Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8(+) T‐cell responses in hepatocellular carcinoma
por: Flecken, Tobias, et al.
Publicado: (2014)